Skip to main content
. 2012 Jul 17;7(7):e37659. doi: 10.1371/journal.pone.0037659

Figure 4. Impact of β1-AR polymorphisms on prognosis of HF.

Figure 4

(A) Arg389 homozygotes vs. Gly389 carriers: all-cause mortality; (B) Arg389 homozygotes vs. Gly389 carriers: combined end-points; (C) Ser49 homozygotes vs. Gly49 carriers: all-cause mortality; (D) Ser49 homozygotes vs. Gly49 carriers: combined end-points. Gly389 carrier: including Arg389Gly and Gly389 homozygotes; Gly49 carrier: including Ser49Gly and Gly49 homozygotes; CI: confidence interval; combined end-points including death, heart transplantation and hospitalization.